Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP)

被引:6
作者
Gomez-Almaguer, David [1 ]
机构
[1] UANL, Univ Hosp, Serv Hematol, Monterrey, NL, Mexico
关键词
Monoclonal antibodies; ITP; Rituximab; Alemtuzumab; Purpura; DOSE RITUXIMAB; ADULTS; EFFICACY; THERAPY; SAFETY;
D O I
10.1179/102453312X13336169155213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune thrombocytopenic purpura is characterized by antibody-mediated destruction of platelets and suboptimal platelet production. Initially the treatment of ITP includes corticosteroids, IgG-anti-D, and intravenous immunoglobulins. Splenectomy and monoclonal antibodies are usually considered for refractory and chronic ITP patients. There are new data suggesting that early administration of rituximab is important, and this antibody has been used as first-line therapy in adults. In this concise review the role of rituximab and other monoclonal antibodies is analyzed. These agents have the capability of sparing splenectomy and possibly curing the disease in some patients.
引用
收藏
页码:S25 / S27
页数:3
相关论文
共 12 条
  • [1] Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
    Arnold, Donald M.
    Dentali, Francesco
    Crowther, Mark A.
    Meyer, Ralph M.
    Cook, Richard J.
    Sigouin, Christopher
    Fraser, Graeme A.
    Lim, Wendy
    Kelton, John G.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (01) : 25 - W5
  • [2] Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
    Dierickx, Daan
    Delannoy, Andre
    Saja, Khalid
    Verhoef, Gregor
    Provan, Drew
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) : 278 - 291
  • [3] Chronic Immune Thrombocytopenia in Adults: Epidemiology and Clinical Presentation
    Fogarty, Patrick F.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (06) : 1213 - +
  • [4] Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
    Godeau, Bertrand
    Porcher, Raphael
    Fain, Olivier
    Lefrere, Francois
    Fenaux, Pierre
    Cheze, Stephane
    Vekhoff, Anne
    Chauveheid, Marie-Paule
    Stirnemann, Jerome
    Galicier, Lionel
    Bourgeois, Emmanuelle
    Haiat, Stephanie
    Varet, Bruno
    Leporrier, Michel
    Papo, Thomas
    Khellaf, Mehdi
    Michel, Marc
    Bierling, Philippe
    [J]. BLOOD, 2008, 112 (04) : 999 - 1004
  • [5] Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias
    Gomez-Almaguer, David
    Solano-Genesta, Manuel
    Tarin-Arzaga, Luz
    Luis Herrera-Garza, Jose
    Graciela Cantu-Rodriguez, Olga
    Homero Gutierrez-Aguirre, Cesar
    Carlos Jaime-Perez, Jose
    [J]. BLOOD, 2010, 116 (23) : 4783 - 4785
  • [6] Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
    Li, Zhenyu
    Mou, Weiwei
    Lu, Guang
    Cao, Jiang
    He, Xupeng
    Pan, Xiuying
    Xu, Kailin
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 91 - 98
  • [7] CAMPATH-1 MONOCLONAL-ANTIBODY THERAPY IN SEVERE REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA
    LIM, SH
    HALE, G
    MARCUS, RE
    WALDMANN, H
    BAGLIN, TP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) : 542 - 544
  • [8] Marsh JC, 2011, CYTOTHERAPY, V3, P189
  • [9] Milani C, 2009, CURR OPIN MOL THER, V11, P200
  • [10] International consensus report on the investigation and management of primary immune thrombocytopenia
    Provan, Drew
    Stasi, Roberto
    Newland, Adrian C.
    Blanchette, Victor S.
    Bolton-Maggs, Paula
    Bussel, James B.
    Chong, Beng H.
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Godeau, Bertrand
    Grainger, John
    Greer, Ian
    Hunt, Beverley J.
    Imbach, Paul A.
    Lyons, Gordon
    McMillan, Robert
    Rodeghiero, Francesco
    Sanz, Miguel A.
    Tarantino, Michael
    Watson, Shirley
    Young, Joan
    Kuter, David J.
    [J]. BLOOD, 2010, 115 (02) : 168 - 186